GLP-1 medications: access, terminology and safety basics
GLP-1-related weight-management treatment has created a crowded telehealth market. A few distinctions make the market much easier to evaluate.
Prescription treatment requires clinical evaluation
An online questionnaire can collect information, but prescription decisions should be made by an appropriately licensed clinician. A platform should not guarantee that you will receive a particular prescription before evaluation.
FDA-approved and compounded are different categories
FDA-approved drugs have undergone FDA review for their approved uses. FDA says compounded drugs are not FDA-approved and do not undergo the same premarket review for safety, effectiveness and quality.
Telehealth does not remove pharmacy due diligence
FDA recommends obtaining a prescription from a doctor and filling it at a state-licensed pharmacy. Consumers should be able to identify the dispensing pharmacy and ask questions about their medication.
- Soul Body Mind Wellness — merchant service information.
- Soul Body Mind Telemedicine Services Policy.
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss.
Merchant details can change. Last editorial verification: September 28, 2026.